Atara Biotherapeutics (ATRA)
(Delayed Data from NSDQ)
$8.27 USD
+0.10 (1.22%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $8.46 +0.19 (2.30%) 5:04 PM ET
3-Hold of 5 3
C Value B Growth B Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -1.25 |
EPS Last Quarter | -5.75 |
Last EPS Surprise | 37.84% |
ABR | 2.71 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -15.75 |
Next Year | -18.33 |
EPS (TTM) | -53.25 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 48.30M | 5.71M | 106.64M | 29.21M |
# of Estimates | 2 | 1 | 2 | 2 |
High Estimate | 56.60M | 5.71M | 117.00M | 42.42M |
Low Estimate | 40.00M | 5.71M | 96.27M | 16.00M |
Year ago Sales | 0.96M | 2.14M | 8.57M | 106.64M |
Year over Year Growth Est. | 4,931.25% | 166.82% | 1,143.85% | -72.61% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.25 | -7.00 | -15.75 | -18.33 |
# of Estimates | 3 | 2 | 3 | 3 |
Most Recent Consensus | 1.50 | -7.00 | -18.25 | -26.25 |
High Estimate | 1.50 | -7.00 | -11.50 | -13.75 |
Low Estimate | -4.50 | -7.00 | -18.25 | -26.25 |
Year ago EPS | -17.00 | -16.50 | -65.25 | -15.75 |
Year over Year Growth Est. | 92.65% | 57.58% | 75.86% | -16.40% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.25 | -7.00 | -15.75 | -18.33 |
7 Days Ago | -1.25 | -7.00 | -15.75 | -18.33 |
30 Days Ago | -1.25 | -7.00 | -15.75 | -18.33 |
60 Days Ago | -1.25 | -7.00 | -15.75 | -18.33 |
90 Days Ago | -8.13 | -11.25 | -32.50 | -7.88 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.25 | -7.00 | -15.75 | -18.33 |
Zacks Consensus Estimate | -1.25 | -7.00 | -15.75 | -18.33 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -5.75 | -14.00 | -16.50 | -17.00 | NA |
Estimate | -9.25 | -15.25 | -15.75 | -16.25 | NA |
Difference | 3.50 | 1.25 | -0.75 | -0.75 | 0.81 |
Surprise | 37.84% | 8.20% | -4.76% | -4.62% | 9.17% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more